1
|
Rivera-Millot A, Slupek S, Chatagnon J, Roy G, Saliou JM, Billon G, Alaimo V, Hot D, Salomé-Desnoulez S, Locht C, Antoine R, Jacob-Dubuisson F. Streamlined copper defenses make Bordetella pertussis reliant on custom-made operon. Commun Biol 2021; 4:46. [PMID: 33420409 PMCID: PMC7794356 DOI: 10.1038/s42003-020-01580-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Accepted: 12/07/2020] [Indexed: 01/29/2023] Open
Abstract
Copper is both essential and toxic to living beings, which tightly controls its intracellular concentration. At the host-pathogen interface, copper is used by phagocytic cells to kill invading microorganisms. We investigated copper homeostasis in Bordetella pertussis, which lives in the human respiratory mucosa and has no environmental reservoir. B. pertussis has considerably streamlined copper homeostasis mechanisms relative to other Gram-negative bacteria. Its single remaining defense line consists of a metallochaperone diverted for copper passivation, CopZ, and two peroxide detoxification enzymes, PrxGrx and GorB, which together fight stresses encountered in phagocytic cells. Those proteins are encoded by an original, composite operon assembled in an environmental ancestor, which is under sensitive control by copper. This system appears to contribute to persistent infection in the nasal cavity of B. pertussis-infected mice. Combining responses to co-occurring stresses in a tailored operon reveals a strategy adopted by a host-restricted pathogen to optimize survival at minimal energy expenditure.
Collapse
Affiliation(s)
- Alex Rivera-Millot
- grid.463727.30000 0004 0386 3856Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Stéphanie Slupek
- grid.463727.30000 0004 0386 3856Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Jonathan Chatagnon
- grid.463727.30000 0004 0386 3856Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Gauthier Roy
- grid.463727.30000 0004 0386 3856Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Jean-Michel Saliou
- grid.410463.40000 0004 0471 8845Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UMS 2014 - PLBS, F-59000 Lille, France
| | - Gabriel Billon
- grid.503422.20000 0001 2242 6780Univ. Lille, CNRS, UMR 8516 – LASIRE – Laboratoire de Spectroscopie pour les Interactions, la Réactivité et l’Environnement, F-59000 Lille, France
| | - Véronique Alaimo
- grid.503422.20000 0001 2242 6780Univ. Lille, CNRS, UMR 8516 – LASIRE – Laboratoire de Spectroscopie pour les Interactions, la Réactivité et l’Environnement, F-59000 Lille, France
| | - David Hot
- grid.410463.40000 0004 0471 8845Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UMS 2014 - PLBS, F-59000 Lille, France
| | - Sophie Salomé-Desnoulez
- grid.463727.30000 0004 0386 3856Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France ,grid.503422.20000 0001 2242 6780Bio Imaging Center Lille platform (BICeL), Univ. Lille, Lille, France
| | - Camille Locht
- grid.463727.30000 0004 0386 3856Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Rudy Antoine
- grid.463727.30000 0004 0386 3856Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Françoise Jacob-Dubuisson
- grid.463727.30000 0004 0386 3856Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France
| |
Collapse
|
2
|
Production of Highly Active Recombinant Dermonecrotic Toxin of Bordetella Pertussis. Toxins (Basel) 2020; 12:toxins12090596. [PMID: 32942577 PMCID: PMC7551409 DOI: 10.3390/toxins12090596] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2020] [Revised: 09/06/2020] [Accepted: 09/10/2020] [Indexed: 11/16/2022] Open
Abstract
Pathogenic Bordetella bacteria release a neurotropic dermonecrotic toxin (DNT) that is endocytosed into animal cells and permanently activates the Rho family GTPases by polyamination or deamidation of the glutamine residues in their switch II regions (e.g., Gln63 of RhoA). DNT was found to enable high level colonization of the nasal cavity of pigs by B. bronchiseptica and the capacity of DNT to inhibit differentiation of nasal turbinate bone osteoblasts causes atrophic rhinitis in infected pigs. However, it remains unknown whether DNT plays any role also in virulence of the human pathogen B. pertussis and in pathogenesis of the whooping cough disease. We report a procedure for purification of large amounts of LPS-free recombinant DNT that exhibits a high biological activity on cells expressing the DNT receptors Cav3.1 and Cav3.2. Electron microscopy and single particle image analysis of negatively stained preparations revealed that the DNT molecule adopts a V-shaped structure with well-resolved protein domains. These results open the way to structure–function studies on DNT and its interactions with airway epithelial layers.
Collapse
|
3
|
Raeven RHM, van Vlies N, Salverda MLM, van der Maas L, Uittenbogaard JP, Bindels THE, Rigters J, Verhagen LM, Kruijer S, van Riet E, Metz B, van der Ark AAJ. The Role of Virulence Proteins in Protection Conferred by Bordetella pertussis Outer Membrane Vesicle Vaccines. Vaccines (Basel) 2020; 8:E429. [PMID: 32751680 PMCID: PMC7563335 DOI: 10.3390/vaccines8030429] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2020] [Revised: 07/16/2020] [Accepted: 07/27/2020] [Indexed: 12/13/2022] Open
Abstract
The limited protective immunity induced by acellular pertussis vaccines demands development of novel vaccines that induce broader and longer-lived immunity. In this study, we investigated the protective capacity of outer membrane vesicle pertussis vaccines (omvPV) with different antigenic composition in mice to gain insight into which antigens contribute to protection. We showed that total depletion of virulence factors (bvg(-) mode) in omvPV led to diminished protection despite the presence of high antibody levels. Antibody profiling revealed overlap in humoral responses induced by vaccines in bvg(-) and bvg(+) mode, but the potentially protective responses in the bvg(+) vaccine were mainly directed against virulence-associated outer membrane proteins (virOMPs) such as BrkA and Vag8. However, deletion of either BrkA or Vag8 in our outer membrane vesicle vaccines did not affect the level of protection. In addition, the vaccine-induced immunity profile, which encompasses broad antibody and mixed T-helper 1, 2 and 17 responses, was not changed. We conclude that the presence of multiple virOMPs in omvPV is crucial for protection against Bordetella pertussis. This protective immunity does not depend on individual proteins, as their absence or low abundance can be compensated for by other virOMPs.
Collapse
Affiliation(s)
- René H. M. Raeven
- Intravacc (Institute for Translational Vaccinology), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands; (N.v.V.); (M.L.M.S.); (L.v.d.M.); (J.P.U.); (T.H.E.B.); (J.R.); (L.M.V.); (S.K.); (E.v.R.); (B.M.); (A.A.J.v.d.A.)
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Abstract
In vitro growth conditions for bacteria do not fully recapitulate the host environment. RNA sequencing transcriptome analysis allows for the characterization of the infection gene expression profiles of pathogens in complex environments. Isolation of the pathogen from infected tissues is critical because of the large amounts of host RNA present in crude lysates of infected organs. A filtration method was developed that enabled enrichment of the pathogen RNA for RNA-seq analysis. The resulting data describe the “infection transcriptome” of B. pertussis in the murine lung. This strategy can be utilized for pathogens in other hosts and, thus, expand our knowledge of what bacteria express during infection. Bordetella pertussis causes the disease whooping cough through coordinated control of virulence factors by the Bordetella virulence gene system. Microarrays and, more recently, RNA sequencing (RNA-seq) have been used to describe in vitro gene expression profiles of B. pertussis and other pathogens. In previous studies, we have analyzed the in vitro gene expression profiles of B. pertussis, and we hypothesize that the infection transcriptome profile in vivo is significantly different from that under laboratory growth conditions. To study the infection transcriptome of B. pertussis, we developed a simple filtration technique for isolation of bacteria from infected lungs. The work flow involves filtering the bacteria out of the lung homogenate using a 5-μm-pore-size syringe filter. The captured bacteria are then lysed to isolate RNA for Illumina library preparation and RNA-seq analysis. Upon comparing the in vitro and in vivo gene expression profiles, we identified 351 and 255 genes as activated and repressed, respectively, during murine lung infection. As expected, numerous genes associated with virulent-phase growth were activated in the murine host, including pertussis toxin (PT), the PT secretion apparatus, and the type III secretion system. A significant number of genes encoding iron acquisition and heme uptake proteins were highly expressed during infection, supporting iron acquisition as critical for B. pertussis survival in vivo. Numerous metabolic genes were repressed during infection. Overall, these data shed light on the gene expression profile of B. pertussis during infection, and this method will facilitate efforts to understand how this pathogen causes infection. IMPORTANCEIn vitro growth conditions for bacteria do not fully recapitulate the host environment. RNA sequencing transcriptome analysis allows for the characterization of the infection gene expression profiles of pathogens in complex environments. Isolation of the pathogen from infected tissues is critical because of the large amounts of host RNA present in crude lysates of infected organs. A filtration method was developed that enabled enrichment of the pathogen RNA for RNA-seq analysis. The resulting data describe the “infection transcriptome” of B. pertussis in the murine lung. This strategy can be utilized for pathogens in other hosts and, thus, expand our knowledge of what bacteria express during infection.
Collapse
|